Andrew J. Rae
Directeur/Membre du Conseil chez University of British Columbia
Postes actifs de Andrew J. Rae
Sociétés | Poste | Début | Fin |
---|---|---|---|
University of British Columbia | Directeur/Membre du Conseil | 02/11/2010 | - |
Historique de carrière de Andrew J. Rae
Anciens postes connus de Andrew J. Rae
Sociétés | Poste | Début | Fin |
---|---|---|---|
SATELLOS BIOSCIENCE INC. | Directeur/Membre du Conseil | 15/02/2005 | 09/03/2020 |
Directeur Général | 15/02/2005 | 09/03/2020 | |
Fondateur | 15/02/2005 | 09/03/2020 | |
Investor Relations Contact | 15/02/2005 | 09/03/2020 | |
President | 15/02/2005 | 09/03/2020 | |
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Directeur/Membre du Conseil | 11/08/2008 | 24/03/2010 |
Liponex, Inc. | Directeur/Membre du Conseil | - | 15/08/2007 |
Ability Biomedical Corp.
Ability Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Part of Bristol Myers Squibb Co., Ability Biomedical Corp. is a Canadian company that researches and develops chemokine-based therapeutics. The company is based in Vancouver, Canada. Ability Biomedical was acquired by Medarex, Inc., part of Bristol Myers Squibb Co. from September 01, 2009 on August 05, 2004 for $8.43 million. | Directeur Financier/CFO | 01/02/2002 | 01/08/2004 |
GLOBAL GAMING TECHNOLOGIES CORP. | Directeur/Membre du Conseil | 26/03/2010 | - |
Independent Dir/Board Member | 19/03/2010 | - | |
Covenant House Vancouver
Covenant House Vancouver Services to the Health IndustryHealth Services Covenant House Vancouver provides shelter and services to children and youth. It offers homeless, runaway and at-risk youth between the ages of 16 and 24 with short-term residential care through its crisis program. The company was founded on September 22, 1997 and is headquartered in Vancouver, Canada. | Directeur/Membre du Conseil | - | - |
Active Pass Pharmaceuticals, Inc.
Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Active Pass Pharmaceuticals, Inc. develops drugs for infectious diseases. It engages in the development of drugs that inhibit ABC transporters. The firm also provides portfolio of therapeutic programs, including age-related macular degeneration, travelers' diarrhea, and lipid disorders. The company was founded by Peter B Reiner in 1998 and is headquartered in Vancouver, Canada. | Directeur Financier/CFO | - | - |
Public Communications Contact | - | - |
Formation de Andrew J. Rae
Simon Fraser University | Masters Business Admin |
University of Western Ontario | Undergraduate Degree |
Statistiques
Internationale
Canada | 11 |
Opérationnelle
Director/Board Member | 6 |
Director of Finance/CFO | 2 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 4 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
GLOBAL GAMING TECHNOLOGIES CORP. | Finance |
Entreprise privées | 6 |
---|---|
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Health Technology |
Liponex, Inc. | Health Technology |
Ability Biomedical Corp.
Ability Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Part of Bristol Myers Squibb Co., Ability Biomedical Corp. is a Canadian company that researches and develops chemokine-based therapeutics. The company is based in Vancouver, Canada. Ability Biomedical was acquired by Medarex, Inc., part of Bristol Myers Squibb Co. from September 01, 2009 on August 05, 2004 for $8.43 million. | Commercial Services |
Active Pass Pharmaceuticals, Inc.
Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Active Pass Pharmaceuticals, Inc. develops drugs for infectious diseases. It engages in the development of drugs that inhibit ABC transporters. The firm also provides portfolio of therapeutic programs, including age-related macular degeneration, travelers' diarrhea, and lipid disorders. The company was founded by Peter B Reiner in 1998 and is headquartered in Vancouver, Canada. | Health Technology |
iCo Therapeutics, Inc.
iCo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology iCo Therapeutics, Inc. is a canadian biotechnology company. It engages in the business of identification, development and commercialization of drug candidates to treat ocular and infectious diseases. Its products include iCo-008 and oral AmpB delivery system. The company was founded by Andrew J. Rae, John G. Clement and William John Meekison on February 15, 2005 and is headquartered in Vancouver, CA. | Health Technology |
Covenant House Vancouver
Covenant House Vancouver Services to the Health IndustryHealth Services Covenant House Vancouver provides shelter and services to children and youth. It offers homeless, runaway and at-risk youth between the ages of 16 and 24 with short-term residential care through its crisis program. The company was founded on September 22, 1997 and is headquartered in Vancouver, Canada. | Health Services |
- Bourse
- Insiders
- Andrew J. Rae
- Expérience